PUBLISHER: Orion Market Research | PRODUCT CODE: 1064774
PUBLISHER: Orion Market Research | PRODUCT CODE: 1064774
Global Hemodialysis Powder Solution Market Size, Share & Trends Analysis Report By Type (Hemodialysis Concentrates, Hemodialysis Dry Powder) By End-User, (Private Clinic, Public Hospital, Personal Care, Nursing Home, Others) Forecast (2020-2026)
The global hemodialysis powder solution market is anticipated to grow at a considerable CAGR during the forecast period. The rising prevalence of chronic kidney disease and cardiovascular disorders that leads to renal failure and the requirement for hemodialysis treatment is driving the global hemodialysis powder solution market. The increasing interference of private organization to increase awareness of such treatments is further anticipated to drive the market growth. In October 2020, The Fresenius Medical Care North America (FMCNA) and Livongo Health, Inc. formed an innovative partnership to improve the lives and outcomes of people with late-stage chronic kidney disease (CKD).
The global hemodialysis powder solution market is segmented based on type and end-user. Based on type, the hemodialysis powder solution market is segmented into hemodialysis concentrates and hemodialysis dry powder. Based on end-user, the hemodialysis powder solution market is segmented into private clinic, public hospital, personal care, nursing home, and others.
Geographically, the global hemodialysis powder solution market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global hemodialysis powder solution market include Baxter International Inc., Rockwell Medical, Inc, O.M.A.R S.r.l Pharmaceutical Blister Solution, and WEGO Health Co., Ltd. among others.
Market Segmentation
The Report Covers